Nucleic Acids Research, 1988, Vol. 16, No. 17 8443-8465
© 1988
Articles |
Cis requirements for alternative splicing of the cardiac troponin T premRNA
Department of Anatomy, University of California San Franscisco, CA 94143, USA
*To whom correspondence should be addressed
Received May 19, 1988. Revised August 2, 1988. Accepted August 2, 1988.
The cardiac troponin T (cTNT) pre-mRNA splices 17 exons contiguously but alternatively splices (includes or excludes) the fifth exon. Because both alternative splice products are processed from the same pre-mRNA species, the cTNT pre-mRNA must contain cis-acting sequences which specify exon 5 as an alternative exon. A cTNT minigene (SM-1) transfected into cultured cells produces mRNAs both including and excluding exon 5. The junctions of exons 4-5-6 and 4-6 in the cTNT minigene mRNAs are identical to those of endogenous cTNT mRNAs and no other exons are alternatively spliced. Thus, the SM-1 pre-mRNA is correctly alternatively spliced in transfected cells. To circumscribe the pre-mRNA regions which are required for the alternative nature of exon 5, we have constructed a systematic series of deletion mutants of SM-1. Tranfection of this series demonstrates that a 1200 nt pre-mRNA region containing exons 4, 5, and 6 is sufficient to direct alternative splicing of exon 5. Within this region are two relatively large inverted repeats which potentially sequester the alternative exon via intramolecular base-pairing. Such sequestration of an alternative exon is consistent with models which propose pre-mRNA conformation as being determinative for alternative splicing of some pre-mRNAs. However, deletion mutants which remove the majority of each of the inverted repeats retain the ability to alternatively splice exon 5 demonstrating that neither is required for cTNT alternative splice site selection. Taken together, deletion analysis has limited cis elements required for alternative splicing to three small regions of the pre-mRNA containing exons 4, 5, and 6. In addition, the cTNT minigene pre-mRNA expresses both alternative splice products in a wide variety of cultured non-muscle cells as well as in cultured striated muscle cells, although expression of the cTNT pre-mRNA is normally restricted to striated muscle. This indicates that cis elements involved in defining the cTNT exon 5 as an alternative exon do not require muscle-specific factors in trans to function.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. M. Stark, T. A. Cooper, and M. B. Roth The Relative Strengths of SR Protein-mediated Associations of Alternative and Constitutive Exons Can Influence Alternative Splicing J. Biol. Chem., October 15, 1999; 274(42): 29838 - 29842. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Bucher, G. K. Dhoot, M. M. Emerson, M. Ober, and C. P. Emerson Jr. Structure and Evolution of the Alternatively Spliced Fast Troponin T Isoform Gene J. Biol. Chem., June 18, 1999; 274(25): 17661 - 17670. [Abstract] [Full Text] [PDF] |
||||
